1[1]Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease. Am J Kidney Dis, 1998, 32: S112-119
2[2]Block GA, Hulbert-Shearon TE, LevinNW, et al. Association of serum phosphorus and calcium×phosphorus product with mortality risk in chronic hemodialysis patients : a national study . Am J Kidney Dis, 1998, 31: 607-617
3[3]Levin NW, Hulberg-shearron TE, Straderman RL, et al. Which causes of death are related to hyperphosphatemia in hemodialysis patients. J Am Soc Nephrol, 1998, 9: 217A (abstr)
4[4]Rumberger JA, Brundage BH, Rader DJ, et al. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc, 1999, 74: 243-252
5[5]Braun J, Oldendorf M, Moshage W, et al. Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients. Am J Kidney Dis, 1996, 27: 394-401
6[6]Farzaneh-Far A, Proudfoot D, Shanhan C, et al. Vascular and valvar calcification: recent advances. Heart, 2001, 85: 13-17
7[7]Celilia M, Giachelli, Shuichi Jono. Vascular calcification and inorganic phosphate. Am J Kidney Dis, 2001, suppl 1: S34-S37
8[8]Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis, 2000, 35: 1226-1237
